With support from a Holden Comprehensive Cancer Center pilot grant, a research team aims to improve the patient experience of the diagnostic period.

Four early-career scientists have each been awarded a one-year, $40,000 American Cancer Society Institutional Research Grant through University of Iowa Holden Comprehensive Cancer Center.

Did smokers do better than non-smokers in a clinical trial for an experimental cancer treatment? That was the intriguing question that led University of Iowa researchers and their colleagues to develop a drinkable, carbon monoxide-infused foam that boosted the effectiveness of the therapy, known as autophagy inhibition, in mice and human cells. The findings were recently published in the journal Advanced Science.